Identification of the dioxygenase-generated intermediate formed during biosynthesis of the dihydropyrrole moiety common to anthramycin and sibiromycin.
Identification of the dioxygenase-generated intermediate formed during biosynthesis of the dihydropyrrole moiety common to anthramycin and sibiromycin.
复制标题
鉴定在蒽霉素和西伯霉素共有的二氢吡咯部分生物合成过程中形成的双加氧酶产生的中间体。
DOI:
10.1016/j.bmc.2014.12.024
复制
发表时间:
2015
影响因子:
3.5
通讯作者:
Rokita,StevenE
中科院分区:
文献类型:
--
作者:
Saha,Shalini;Li,Wei;Gerratana,Barbara;Rokita,StevenE
A description of pyrrolo[1,4]benzodiazepine (PBD) biosynthesis is a prerequisite for engineering production of analogs with enhanced antitumor activity. Predicted dioxygenases Orf12 and SibV associated with dihydropyrrole biosynthesis in PBDs anthramycin and sibiromycin, respectively, were expressed and purified for activity studies. UV–visible spectroscopy revealed that these enzymes catalyze the regiospecific 2,3-extradiol dioxygenation ofl-3,4-dihydroxyphenylalanine (l-DOPA) to forml-2,3-secodopa (λmax= 368 nm).1H NMR spectroscopy indicates thatl-2,3-secodopa cyclizes into the α-keto acid tautomer ofl-4-(2-oxo-3-butenoic-acid)-4,5-dihydropyrrole-2-carboxylic acid (λmax= 414 nm). Thus, the dioxygenases are key for establishing the scaffold of the dihydropyrrole moiety. Kinetic studies suggest the dioxygenase product is relatively labile and is likely consumed rapidly by subsequent biosynthetic steps. The enzymatic product and dimeric state of these dioxygenases are conserved in dioxygenases involved in dihydropyrrole and pyrrolidine biosynthesis within both PBD and non-PBD pathways.